Skip to content

Over 30 years, big fall in HIV among people who inject drugs in Baltimore, but hepatitis C remains high

Yellow containers of syringes at a needle exchange in Melbourne, Australia.

Top 5 stories on HIV and women from CROI 2024

Professor Risa Hoffman, presenting findings from the IMPAACT 2010 study, at CROI 2024. Photo by Roger Pebody.

Top 5 HIV PrEP stories from CROI 2024

Dr Brenda Mirembe, lead researcher on the INSIGHT PrEP study, at CROI 2024. Photo by Roger Pebody.

Long-acting injectables can be a good option for people with adherence challenges

Dr Aadia Rana at CROI 2024. Photo by Roger Pebody.

Top 5 stories on co-morbidities affecting people with HIV from CROI 2024

Dr Jordan Lake at CROI 2024. Photo by Roger Pebody.

Should event-driven PrEP be an option for women?

Dr Jenell Stewart at CROI 2024.

Nearly two million people in sub-Saharan Africa may have advanced HIV disease

Dr Dominik Stelzle at CROI 2024. Photo by Krishen Samuel.

Top 5 HIV treatment stories from CROI 2024

Dr George Bello at CROI 2024. Photo by Roger Pebody.

Semaglutide improves fatty liver disease and inflammation in people with HIV

Dr Jordan Lake at CROI 2024. Photo by Roger Pebody.